Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

InMed Pharmaceuticals Inc INM

InMed Pharmaceuticals Inc. is a pharmaceutical company. It develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharmaceuticals segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its pharmaceutical pipeline consists of three programs, with drug candidates targeting Alzheimer’s disease, dry age-related macular degeneration, and Epidermolysis Bullosa. Its INM-901 is a drug candidate being developed as a potential treatment for Alzheimer’s disease. Its INM-089 is cannabinoid analog being studied for its potential as a treatment for age-related macular degeneration. Its INM-755 is a cannabinol topical cream which has completed Phase 2 clinical trial studies for the treatment of epidermolysis bullosa.


NDAQ:INM - Post by User

Bullboard Posts
Comment by RedDeerMoneymanon Sep 11, 2015 10:42am
214 Views
Post# 24096011

RE:Reverse Split

RE:Reverse SplitFinally someone who is reading between the lines!
I like that you highlighted the last line.
To everyone one else who is thinking about jumping ship at a high volume rate, ask yourself this one question.
Who do you think was buying all the shares this past Tuesday, knowing full well the weak share holders were going to dump?

Ive said this before, we as shareholders need to support this stock after every news release, instead of having people short it all the time.
We all know the 4 for 1 rollback is going to pass. ( both my wife and I voted for it).
Its going to be up to us as SH to support the next NEWS RELEASES. If we don't then management will have but now choice to execute the roll back to move this company forward before February.

Either way I'm going to be happy with my share volume, but would be happier without losing 75% especially, when this starts trading in the dollars.

if you think I'm full of BS take a look at my track record, Actual Due Diligence works even if it is written in riddles.
fyi if you go back to June Laroo and I have since made a mense.

GLTA
Bullboard Posts